PREP in neurodegenerative disorders -group will be presenting their recent results in AD/PD 2015 congress in Nice, France. The congress will be having over 3000 participants, and all the Alzheimer’s and Parkinson’s disease top researchers will be contributing to scientific program.

Our team will be presenting in two posters, one by Mari Savolainen with the topic “PROLYL OLIGOPEPTIDASE INHIBITION ATTENUATES THE TOXICITY OF PROTEASOMAL INHIBITION IN ALPHA-SYNUCLEIN OVEREXPRESSING CELLS AND IN PARKINSON’S DISEASE MOUSE MODEL” and the other in collaboration with Dr. Henri Huttunen’s group titled “PROLYL OLIGOPEPTIDASE MODULATES ALPHA-SYNUCLEIN OLIGOMERIZATION VIA DIRECT PROTEIN-PROTEIN INTERACTION“.